Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Carterra

Request full access

Developing biotechnology solutions focused on innovative micro-array deposition technologies to enhance research and analysis

Salt Lake City, United StatesFounded 2005Biotech & Life Sciences

About Carterra

Carterra is a biotechnology company revolutionizing antibody discovery and characterization through its high-throughput surface plasmon resonance (HT-SPR™) technology. Headquartered in the United States, Carterra develops and manufactures powerful analytical instruments that enable pharmaceutical and biotech companies to accelerate therapeutic discovery, particularly in antibody and small molecule drug development.

At the heart of Carterra’s offering is its proprietary HT-SPR™ platform, with instruments like the Carterra LSA, LSA XT, and Ultra, which allow researchers to rapidly generate high-resolution data on antibody kinetics, binding affinities, and epitope diversity—all while using only a fraction of the sample volume typically required. These instruments allow simultaneous screening and in-depth characterization of hundreds of antibody interactions in a single run, drastically reducing the time and cost of the drug discovery process.

Carterra’s technology is widely adopted by leading pharmaceutical companies, research institutions, and biotech firms seeking to make data-driven decisions at the earliest stages of therapeutic development. Their platforms are used for a range of applications including epitope binning, antibody affinity profiling, fragment screening, and characterization of difficult targets such as GPCRs and kinases.

The company’s technology played a critical role in the development of Eli Lilly’s COVID-19 therapeutic, demonstrating the real-world impact and scalability of its high-throughput capabilities. With integrated AI and machine learning tools, Carterra is also helping researchers unlock deeper insights from complex biological data, enabling a new era of precision in drug development.

By offering unmatched throughput, resolution, and efficiency, Carterra is setting a new standard in biologics discovery and helping to bring life-saving therapies to market faster.

Source: Dealroom company data

Carterra in the Salt Lake City ecosystem

Live from Dealroom

The Carterra office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A2 investors entered at this stage

  • Tech Coast Angels
  • Kirk Ririe

Series B and later3 investors entered at this stage

  • Telegraph Hill Partners
  • Ballast Point Ventures
  • PerkinElmer
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Carterra on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.